GBP1 Antibodies

Santa Cruz Biotechnology offers a broad range of GBP1 monoclonal antibodies for investigating GBP1's role in various biological processes. GBP1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GBP1, or Guanylate Binding Protein 1, is a critical component of the immune response, playing a significant role in the regulation of inflammation and the defense against intracellular pathogens. GBP1's function in GTPase activity and modulation of cellular signaling pathways highlights its importance in both innate and adaptive immunity. Understanding GBP1's mechanisms can provide insights into various diseases, including infections and autoimmune disorders. Research focused on GBP1 continues to reveal new aspects of immune system regulation and cellular defense mechanisms. Investigating GBP1's role in different physiological and pathological conditions helps advance our understanding of immune responses and disease progression. GBP1 research has implications for developing new therapeutic strategies for inflammatory and infectious diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system regulation and disease mechanisms.